"Breakthrough Study Shows MDMA Therapy's Promise for PTSD Treatment"
A Phase III trial has found that MDMA-assisted therapy is effective in relieving symptoms of post-traumatic stress disorder (PTSD) when compared to standard therapy. The study involved over 100 participants with moderate to severe PTSD and showed that 86% of the MDMA group achieved a "clinically meaningful" improvement in symptoms compared to 69% of the control group. The nonprofit organization funding the research plans to seek formal approval from the FDA for MDMA-assisted therapy before the end of the year. If approved, this treatment could provide a valuable new option for individuals who haven't responded to existing medications or therapy.